These findings stand in sharp contrast to the marked ability of IKKβ inhibition to prevent TNFα expression and release, an endpoint that raised enthusiasm for targeting IKKβ in chronic inflammatory diseases such as rheumatoid arthritis and inflammation-induced bone loss45. The gene discussed is IKBKB; the disease is rheumatoid arthritis.